Lucy Scientific Discovery Inc LSDI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LSDI is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.87
- Day Range
- $0.72–0.85
- 52-Week Range
- $0.72–17.00
- Bid/Ask
- $0.74 / $0.82
- Market Cap
- $1.34 Mil
- Volume/Avg
- 71,242 / 49,212
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 69.51
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.lucyscientific.com
Valuation
|
Metric
|
LSDI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 18.92 |
Price/Sales | 69.51 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LSDI
|
|---|---|
Quick Ratio | 0.06 |
Current Ratio | 0.38 |
Interest Coverage | −5.70 |
Quick Ratio
LSDI
Profitability
|
Metric
|
LSDI
|
|---|---|
Return on Assets (Normalized) | −126.70% |
Return on Equity (Normalized) | −639.90% |
Return on Invested Capital (Normalized) | −171.83% |
Return on Assets
LSDI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gqkqfzhp | Cjzhw | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Bvzpvzwpzg | Qkkdyw | $70.8 Bil | |
HLN
| Haleon PLC ADR | Kxddztpvz | Lrc | $38.2 Bil | |
VTRS
| Viatris Inc | Ldccwwpc | Nmt | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xpxrldtfk | Wyh | $12.5 Bil | |
CTLT
| Catalent Inc | Hfyqyzrs | Tbsrxd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Bcnjrlglj | Lkhhn | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Fndsnwc | Cxl | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bhvnrntd | Gthnkv | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Hlmzjdchdm | Rclhy | $2.9 Bil |